Literature DB >> 7578618

Multicentre evaluation of a non-wipe system for the rapid determination of total cholesterol in capillary blood, Accutrend Cholesterol on Accutrend GC.

H D Gottschling1, W Reuter, G Ronquist, A Steinmetz, A Hattemer.   

Abstract

Accutrend Cholesterol, a non-wipe test for the determination of total cholesterol in capillary blood, was evaluated at four clinical centres. Cholesterol determinations with the Accutrend system using capillary blood were compared with results obtained with the cholesterol oxidase/p-aminophenazone (CHOD-PAP) method using the respective capillary sera. Triacylglycerols, uric acid and haematocrit were determined to evaluate potential interference. Imprecision measurements were performed with venous blood. To examine the reproducibility of results from lot to lot, three different lots of test strips were included in these investigations. Results with Accutrend Cholesterol agree with those of the comparison method within systematic differences of +2.5% to -3.2%, depending on the lot. There was no interference by triacylglycerols up to 10.28 mmol/l (900 mg/dl), by uric acid 60 to 400 mumol/l (1 mg/dl to 7 mg/dl), or by haematocrits between 0.35 and 0.54. Impression data show coefficients of variation of generally less than 5%. Thus Accutrend Cholesterol proved to be a reliable system for the determination of total cholesterol.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7578618

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  2 in total

1.  Comparative evaluation of ultramicro-and macro-chemo enzyme based assays of glucose, cholesterol and triglycerides.

Authors:  G Yogeeswaran; C E Jebaraj; V Sriram
Journal:  Indian J Clin Biochem       Date:  1999-07

2.  Reproducibility, accuracy and concordance of Accutrend Plus for measuring circulating lipid concentration in adults.

Authors:  Aldo Scafoglieri; Jonathan Tresignie; Steven Provyn; Jan Pieter Clarys; Ivan Bautmans
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.